Entering text into the input field will update the search result below

FDA OKs Johnson & Johnson Vision's Acuvue Abiliti Overnight lenses for myopia

  • Johnson & Johnson (NYSE:JNJ) unit announces that the FDA has approved ACUVUE Abiliti Overnight Therapeutic Lenses.
  • This is the first and only FDA approved orthokeratology (ortho-k) contact lens for the management of myopia.
  • Abiliti Overnight contact lenses are expected to be available in

Recommended For You

About JNJ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
JNJ--
Johnson & Johnson